The opposition to BT brinjal has partly arisen because some Solanum species are widely used in Indian medicine. According to Prof.

The activists opposing the commercialization of Bt brinjal have asserted that Bt brinjal would seriously affect the use of brinjal in the Alternative and Complementary Systems of Medicine (ACSM) in India, through ‘loss of synergy’. The then Minister for Environment and Forests (MoEF), Government of India (GoI), repeatedly echoed this view.

The report reviews the decision by the Indian regulatory authority to stall the commercial release of transgenic crops containing the reporter gene GUS because of environmental implications, though scientists have concluded it safe. This decision will impact many crops, including those developed for drought and salt tolerance.